Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

Nature

Volumn 394, Issue 6692, 1998, Pages 482-485

  Klenerman, Paul ^a   Zinkernagel, Rolf M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS MUTATION;

ANIMALS; EPITOPES, T-LYMPHOCYTE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MODELS, IMMUNOLOGICAL; MUTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032581491     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/28860     Document Type: Article

References (30)

1. Phillips, R. E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459 (1991).
2. Bertoletti, A. et al. Cytotoxic T lymphocyte resonse to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180, 933-943 (1994).
3. Pircher, H. et al. Viral escape by selection of cytotoxic T cell-resistant variants in vivo. Nature 346, 629-233 (1990).
4. Bertoletti, A. et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410 (1994).
5. Klenerman, P. et al. Naturally occurring HIV-1 gag variants antagonize cytotoxic T-cell activity. Nature 369, 403-406 (1994).
6. Francis, T. Influenza: The newe acquayantance. Ann. Intern. Med. 39, 203-212 (1953).
7. De St Groth, F. & Webster, R. Disquisitions on original antigenic sin. I. Evidence in man. J. Exp. Med. 124, 331-345 (1966).
8. De St Groth, F. & Webster, R. Disquisitions on original angigenic sin. II. Proof in lower creatures. J. Exp. Med. 124, 347-361 (1966).
9. Hotchin, J. The biology of LCMV infection: Virus induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27, 470-488 (1962).
10. Aebischer, T., Moskophidis, D., Rohrer, U. H., Zinkernagel, R. M. & Hengartner, H. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc. Natl Acad. Sci. USA 88, 11047-11051 (1991).
11. Moskophidis, D. & Zinkernagel, R. M. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69, 2187-2193 (1995).
12. Jacobson, S. & Pfau, C. Viral pathogenesis and resistance to defective interfering particles. Nature 283, 311-315 (1980).
13. Klenerman, P., Hengartner, H. & Zinkernagel, R. A non-retroviral RNA virus persists in DNA form. Nature 390, 298-301 (1997).
14. Lewicki, H. et al. CTL escape variants. 1. Generation and molecular characterization. Virology 210, 29-40 (1995).
15. Good, M., Zevering, Y., Currier, J. & Bilsborough, J. Original antigenic sin, T cell memory and malaria sporozoite immunity: an hypothesis for immune evasion. Parasite Immunol. 15, 187-193 (1993).
16. Halstead, S., Rojanasuphot, S. & Tsurukubo, Y. Original antigenic sin in dengue. Am. J. Hyg. Trop. Med. 32, 154-156 (1983).
17. Nara, P. L. et al. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J. Virol. 64, 3779-3791 (1990).
18. Evavold, B. & Allen, P. Separation of IL-4 production from proliferation by an altered peptide ligand. Science 252, 1308-1310 (1991).
19. d restricted CTL clones specific for a photoreactive peptide derivative. J. Exp. Med. 185, 629-640 (1997).
20. Jameson, S. C. & Bevan, M. J. T cell receptor antagonists and partial agonists. Immunity 2, 1-11 (1995).
21. Butz, E. & Bevan, M. Massive expansion of antigen-specific CD8+ cells during acute virus infection. Immunity 8, 167-175 (1998).
22. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).
23. Gallimore, A. et al. Induction and exhaustion of LCMV-specific CTL visualised using soluble tetrameric MHC-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
24. Klenerman, P., Meier, U. C., Phillips, R. E. & McMichael, A. J. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immunol. 25, 1927-1931 (1995).
25. McAdam, S. N. et al. Immunogenic HIV variants that bind to HLA-B8 but fail to stimulate CTL responses. J. Immunol. 155, 2729-2736 (1995).
26. Weiner, D. et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a CTL escape variant. Proc. Natl Acad. Sci. USA 82, 2755-2759 (1995).
27. Kent, S., Greenberg, P., Hoffman, M., Akridge, R. & McElrath, M. Antagonism of vaccine induced HLV-1 specific CD4 T cells by primary HIV-1 infection. Potential mechanism of vaccine failure. J. Immunol. 158, 807-815 (1997).
28. Zinkernagel, R. M. Immunology taught by viruses. Science 271, 173-178 (1996).
29. Bachmann, M. F., Speiser, D. & Ohashi, P. Functional Maturation of an antiviral CTL response. J. Virol. 71, 5764-5768 (1997).
30. Battegay, M. et al. Quantification of LCMV with immunological focus assay in 24 or 96 well plates. J. Virol. Meth. 33, 191-198 (1991).